Human Ultracell VI: Woman
Longevity
Activator.
Oral presentation.
Contains 6 different formulas per dosage.
3
capsules differentiated in formulas, engraving and color of 750 mg each.
3 tablets differentiated in formulas, engraving and color of 750 mg
each
Dr. Patrick Human Ultracell
VI
Composition:
Each Enteric Coated White Tablet 750 mg contains:
Opotherapeutic Extracts: Umbilical cord, Embryo, Placenta, Thymus,
Mesenchyme, Muscle, Ovary.
Peptide Extracts: Umbilical Cord, Embryo, Placenta, Thymus, Mesenchyme,
Muscle, Ovary.
Other Assets: Adénine Diphospirine Dinucléotide (NAD),
Trans-Resveratrol 3-4-5, Superoxide Dismutase, Glutathione Peroxidase,
Glutathione Reductase, Glutathione Transferase, Adenosine Triphosphate (ATP),
Vitamin B1 Complex, Vitamin A, Potassium gluconate, Osteol, Vinpocetine,
Pregnenolone, stabilizers and excipients.
Composition:
Each enteric-coated 750 mg Red Tablet contains:
Opotherapeutic Extracts: Umbilical cord, Embryo, Placenta, Thymus,
Heart, Lung, Uterus.
Peptide Extracts: Umbilical cord, Embryo, Placenta, Thymus, Heart,
Lung, Uterus.
Other Assets: Adénine Diphospirine Dinucléotide (NAD),
Trans-Resveratrol 3-4-5, Vinpocetine, Pregnenolone, Lycopene, Hydroxytyrosol,
Vitamin B9, Vitamin H, Copper Gluconate, Lapacho, Exocyan, Adenosine
triphosphate (ATP) Superoxide Dismutase, Glutathione Peroxidase, Glutathione
Reductase, Glutathione Transferase, stabilizers and excipients.
Composition:
Each enteric-coated 750 mg Gray Tablet contains:
Opotherapeutic Extracts: Umbilical Cord, Embryo, Thymus Placenta,
Liver, Pancreas, Ovary.
Peptide Extracts: Umbilical Cord, Embryo, Placenta, Thymus, Liver,
Pancreas, Ovary.
Other Assets: Adénine Diphospirine Dinucléotide (NAD),
Trans-Resveratrol 3-4-5, Vitamin B12, Calcium Phosphate, Manganese Gluconate,
Vinoserae, Zinc Gluconate, Adenosine Triphosphate (ATP), Vinpocetine ,
Pregnenolone, Superoxide Dismutase, Glutathione Peroxidase, Glutathione
Reductase, Glutathione Transferase, stabilizers and excipients.
Composition:
Gray Capsule 750 mg contains:
Opotherapeutic Extracts: Umbilical Cord, Embryo, Placenta, Thymus,
Bones, Adrenal, Uterus.
Peptide Extracts: Umbilical Cord, Embryo, Thymus, Placenta, Bones,
Adrenal, Uterus.
Other Assets: Adénine Diphospirine Dinucléotide (NAD),
Trans-Resveratrol 3-4-5, Vitamin C, Vitamin E, Magnesium Gluconate, Adenosine
Triphosphate (ATP), Riboflavin, Thiamine, Isonicotinate, Hypericin, Superoxide
Dismutase, Glutathione Peroxidase, Glutathione Reductase, Glutathione
Transferase, stabilizers and excipients.
Composition:
Red Capsule 750 mg contains:
Opotherapeutic Extracts: Umbilical Cord, Embryo, Thymus, Placenta,
Kidney, Ovary.
Peptide Extracts: Umbilical Cord, Embryo, Thymus, Placenta, Ovary,
Kidney.
Other Assets: Adénine Diphospirine Dinucléotide (NAD),
Trans-Resveratrol 3-4-5, Vitamin C, Vitamin B5, Ferric Gluconate, Ginseng,
Vinitrox, Vinoseed, Adenosine Triphosphate (ATP), Riboflavin, Thiamine ,
Isonicotinate, Hypericin, Superoxide Dismutase, Glutathione Peroxidase,
Glutathione Reductase, Glutathione Transferase, stabilizers and excipients.
Composition:
750 mg Red / Gray Capsule contains:
Opotherapeutic Extracts: Umbilical Cord, Embryo, Thymus, Placenta,
Brain, Uterus.
Peptide Extracts: Umbilical Cord, Embryo, Thymus, Placenta, Uterus,
Brain.
Other Assets: Adénine Diphospirine Dinucléotide (NAD),
Trans-Resveratrol 3-4-5, Vitamin B6, Vitamin B2, Zinc Gluconate, Adenosine
Triphosphate (ATP), Riboflavin, Thiamine, Isonicotinate, Hypericin, Superoxide
Dismutase, Glutathione Peroxidase, Glutathione Reductase, Glutathione
Transferase, stabilizers and excipients.
Indications:
- Regeneration, revitalization and cell renewal for human longevity, through
the reinforcement of the immune system.
- Adjuvant in degenerative diseases of the immune system.
- Premature aging.
- Decreased mental and physical faculties, fatigue, physical asthenia.
- Prevention of degenerative diseases.
- General energy increase.
- Revitalization of bodily functions.
- Increased resistance to stress.
- Improved performance and organic function that weakens with aging.
- Remarkable improvement in physical performance.
- Improved blood pressure.
- Recovery of concentration and memory capacity.
- Improved quality of sleep.
- Prevention of osteoporosis.
- Stimulation and control of libido in men and women.
- Strengthening of the venous system, acceleration of wound recovery.
- Stimulation of endogenous production of growth hormone that maintains muscle
mass.
- Prevention of senescence keeping the patient as a young adult.
Mechanism of action
The
Human Ultracell VI formula
contains cellular and phytochemical biological compounds, which are administered
to the patient orally or intramuscularly, and once in the body are transported
to the bloodstream reaching the blood capillaries and from there to the
extracellular matrix. The extracellular matrix is a network of molecules,
proteins and carbohydrates that are arranged in the intercellular space and that
are synthesized and secreted by the cells themselves. From the extracellular
matrix the components of the formula pass into the cells, through the cellular
means available for it, mainly endocytosis.
Human-Ultracell VI contains a large number of cellular
components, embryonic growth factors, nucleotides and cytokines, which require
massive incorporation into the cell. In this massive incorporation,
extracellular molecules can enter the vesicle nonspecifically, in solution, or
specifically bound to membrane receptors, termed endocytosis and pinocytosis.
Endocytosis consists of a transport medium according to which the cell forms a
depression in its membrane, which engulfs the elements to be incorporated,
forming a vacuole that then closes around these elements and transports them to
assimilation and digestion bags called Lysosomes, where they are catabolized and
assimilated.
Pinocytosis is a type of nonspecific endocytosis of dissolved molecules. Some of
the contents of any vesicle that forms on the plasma membrane will have
dissolved molecules that have seeped into the vesicle in a non-specific manner.
To a greater or lesser extent, all endocytosis routes carry out pinocytosis.
Cycles of the Mechanism of Action
The cell renewal process
occurs continuously and its efficiency depends on the physiological state or
physiological age of the patient, in other words on their degree of
deterioration. Although we cannot speak of defined stages of therapy action, we
can use the concept of cycles to define the sequence of its renewal processes.
CYCLE 1
CELL REVITALIZATION: The high content of coenzymes NAD
(Nicotinamide Adenine Dinucleotide) of the formula, essential for the efficient
production of energy of the cell, in the phase of Oxidative Phosphorylation,
together with the inducers of proliferation of mitochondria of the formula,
almost immediately contribute to increasing the production of cellular energy,
which allows cells to develop a process of AUTOPHAGY, cell cleaning, to get rid
of denatured proteins and other useless biological material, accumulated in
their cytoplasm as a result of poor functioning cell functions over time. Said
biological material is digested in lysosomes, or vesicles of digestion by
hydrolase enzymes, to be reused in the production of new proteins for the body.
Cells freed from the overwhelming burden of biological waste, and with increased
energy production, undergo a great revitalization. It is important to note that
AUTOPHAGY takes on special significance in the case of cells that do not divide,
such as neuronal and cardiac cells, and those that divide little, reducing the
risk of accumulation of harmful proteins that hinder their functions. It is
worth mentioning that Alzheimer’s disease is associated with the accumulation of
amyloid proteins in neurons. It has recently been discovered that the coenzymes
NAD are not only essential for the efficient production of cellular energy,
adenosine triphosphate (ATP), but also that they are key for efficient
intracellular communication in the chronological execution of their functions,
hence a decrease in its amount in cells, contributes to aging.
CYCLE 2
CELL RENEWAL: With the progressive recovery of the energy
production capacity induced by the formula and by the effects of the growth
factor stimulating cytokines in the formula, a process of normalization of
cellular functions begins, particularly its machinery for the production of
membrane proteins and lipids. In this cycle, the controls in the transcription
of DNA into messenger RNA and translation into proteins are also reinforced, to
avoid errors in the amino acid sequence of said proteins. In addition, the
semi-conservative replication mechanisms of DNA are reinforced, prior to mitosis
at the cellular interface and the cellular capacity to correct copying errors.
In addition, cells improve their protection mechanisms against mutations,
reinforcing their capacity for apoptosis of mutated cells.
CYCLE 3
ORGANIC RECOVERY: The normalization of cellular functions leads to a
greater production of proteins, which translates into an increase in muscle
mass, an increase in collagen in the skin, joints, connective tissue,
improvement of liver, kidney, and lung function, cardiovascular, in addition to
cognitive functions, memory, ability to concentrate, etc. and stimulates the
immune system. The synergistic action of the amino acids and catalyst peptides
of Human Ultracell induces and stimulates the pituitary gland to release a
greater proportion of human growth hormone (whose production decreases
appreciably with age), which acts directly on all tissues of the body, causing
the activation of a younger metabolism, characterized by an increase in protein
synthesis in almost all cells of the body, increased mobilization of fatty acids
from adipose tissue, increased amount of free fatty acids in the blood and
preferential use of fatty acids as an energy source instead of glucose. This
cycle almost always begins in week 3 or 4 and reaches its peak within 6 months.
Administration:
Orally, consume before taking food to improve absorption, preferably with water
in the morning.
Dosage:
Corresponds to 4500 mg for each daily dose consisting of the contents of 1 vial
containing 6 pills (capsules and/or tablets) of 750 mg each. Each pill is
specially formulated for prolonged release to withstand digestive enzymes
facilitating absorption in the small intestine. Daily doses are provided in the
contents of individual vials intended to be taken daily. We recommend the
contents of each vial be taken once opened within that day. The packaging is
comprised of 3 cycles containing 5 daily doses each (15 vials total). Treatment
should be implemented in the following nature Cycle 1 for 5 days taking contents
of 1 vial daily (six pills). Cycle 1 should be followed by Cycle 2 for 5 days
consuming the contents of 1 vial daily. Cycle 2 should be followed by Cycle 3
for 5 days consuming contents of one vial daily. This 15-day regiment should be
repeated for another 15 days in the same manner to complete a 30 day monthly
recommended treatment. This dosing should be completed without intervals or
interruption. Follow up dosing should be implemented according to patient’s age
and doctor recommendation.
Human Ultracell VI Oral Protocol:
Depending on the condition and age, the dosage orientation varies to optimize
the effectiveness of the treatment.
Indications for taking the product.
Posology 1 Preventive Therapy.
As preventive therapy in asymptomatic patients to prevent degenerative diseases
and slow down aging.
Frequency and dose by age.
From 30 to 39 years 30 doses and repeat every 6 months. *
From 40 to 49 years 30 doses and repeat every 4 months. *
From 50 to 59 years 30 doses and repeat every 3 months. *
After 60 years, 30 doses and repeat every 2 months. *
* Each dose corresponds to one dose per day.
* Restart annually for equal periods according to age.
IMPORTANT:
Do not interrupt the recommended doses of treatment, its therapeutic effect is
of continuous action, its effectiveness will depend on the completion of the
treatment.
Posology 2 Clinical treatment.
As Adjuvant Therapy for symptomatic
patients suffering from a disorder or disease, or people with a marked family
genetic inheritance to contract diseases.
Frequency and dose by age.
From 30 to 39 years 45 doses every 6 months.
*
From 40 to 49 years 45 doses every 4 months. *
From 50 to 59 years 45 doses every 3 months. *
After 61 years 45 doses every 2 months. *
* Each dose corresponds to one dose per day.
* Restart dose cycles for equal periods annually.
Chronic diseases it is recommended to consult a doctor for the corresponding
indication.
IMPORTANT:
Do not interrupt the recommended doses, its therapeutic effect is of continuous
action, its effectiveness will depend on the continuity of the treatment.
Side effects:
Due to its peptide and opotherapeutic content in its formula, it could in some
cases cause a slight headache, which disappears after a few minutes, nausea is
very occasional and disappears in a few hours.
Extraction and obtaining of biopeptides and cellular extracts
It should
be noted that the formulas contain biological components of animal origin in
combination with other compounds that enhance the therapeutic action and are
extracted especially in the embryonic stage and processed during the second
month of gestation, these components that are part of the formulas of some of
Our products are obtained after a long biochemical process and are certified
free of prions, pyrogens, bacteria, nano-bacteria, fungi, viruses and after many
controls, the risks of an immune reaction in Humans are 100% eliminated.
Many years of clinical experience has shown that pigs and sheep are the best
donors, because they are strong and immunologically resistant. Proof of this is
that even in the 21st century, most heart valve transplants for humans are
derived from pigs, in addition to insulin and many derived products for
therapeutic purposes, come from these. These methods are continuously monitored
to determine that they meet the strictest standards required by biosafety for
therapeutic purposes. All the components and other active ingredients of the
formulas are also approved by the Federal Food and Drug Agency
(FDA) and are manufactured in the USA by BIOCELL
ULTRAVITAL USA under Swiss license from Biocell
Ultravital.
Contraindication.
It can be safely combined with other medications.
In the recommended doses, no adverse reactions have been observed in any case.
Presentation and packaging:
Contains 45 enteric-coated tablets and 45
enteric-coated capsules with engraving and different colors that are packaged in
15 sterile vials with stoppers and security seal with the printed name of the
brand on tear-off to preserve quality of each of its different formulas and
presentations.
Conservation:
Keep in a dry and cool place at room temperature between 5
° C and 40 ° C. Do not use after the expiration date, nor when the present vial
has broken the safety cap, nor when the outer packaging is open or forced.
Control of finished product:
Two (2) independent laboratories perform various tests and mycotic controls,
biological, bacteriological type 5 analyzes, multicenter immunocellular tests,
Anti brucellosis, Virological controls, multiple anti-prion tests, Bacteriosis,
Cyclospores, Mycobacteria, Salmonellosis in accordance with the subject of
biology for therapeutic purposes for human consumption according to current EC
regulations
Warning:
Biocell Ultravital guarantees the purity and quality of its
products and is not responsible for damage to third parties that may cause
malpractice.
